These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25289928)

  • 41. TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation.
    Marahleh A; Kitaura H; Ohori F; Kishikawa A; Ogawa S; Shen WR; Qi J; Noguchi T; Nara Y; Mizoguchi I
    Front Immunol; 2019; 10():2925. PubMed ID: 31921183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption.
    Tan SD; de Vries TJ; Kuijpers-Jagtman AM; Semeins CM; Everts V; Klein-Nulend J
    Bone; 2007 Nov; 41(5):745-51. PubMed ID: 17855178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor-host cell interactions in the bone disease of myeloma.
    Fowler JA; Edwards CM; Croucher PI
    Bone; 2011 Jan; 48(1):121-8. PubMed ID: 20615487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Osteocyte apoptosis.
    Jilka RL; Noble B; Weinstein RS
    Bone; 2013 Jun; 54(2):264-71. PubMed ID: 23238124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
    Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
    PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Importance of osteocyte-mediated regulation of bone remodelling in inflammatory bone disease.
    Intemann J; De Gorter DJJ; Naylor AJ; Dankbar B; Wehmeyer C
    Swiss Med Wkly; 2020 Jan; 150():w20187. PubMed ID: 32031236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of fluoride on osteocyte-driven osteoclastic differentiation.
    Jiang N; Guo F; Xu W; Zhang Z; Jin H; Shi L; Zhang X; Gao J; Xu H
    Toxicology; 2020 Apr; 436():152429. PubMed ID: 32156525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osteocytes respond to particles of clinically-relevant conventional and cross-linked polyethylene and metal alloys by up-regulation of resorptive and inflammatory pathways.
    Ormsby RT; Solomon LB; Yang D; Crotti TN; Haynes DR; Findlay DM; Atkins GJ
    Acta Biomater; 2019 Mar; 87():296-306. PubMed ID: 30690207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Myeloma bone disease].
    Abe M
    Clin Calcium; 2014 Aug; 24(8):1159-68. PubMed ID: 25065867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteocytes control myeloid cell proliferation and differentiation through Gsα-dependent and -independent mechanisms.
    Azab E; Chandler KB; Uda Y; Sun N; Hussein A; Shuwaikan R; Lu V; Costello CE; McComb ME; Divieti Pajevic P
    FASEB J; 2020 Aug; 34(8):10191-10211. PubMed ID: 32557809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro.
    Al-Dujaili SA; Lau E; Al-Dujaili H; Tsang K; Guenther A; You L
    J Cell Biochem; 2011 Sep; 112(9):2412-23. PubMed ID: 21538477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction.
    Sabol HM; Amorim T; Ashby C; Halladay D; Anderson J; Cregor M; Sweet M; Nookaew I; Kurihara N; Roodman GD; Bellido T; Delgado-Calle J
    Neoplasia; 2022 Jun; 28():100785. PubMed ID: 35390742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Iron Overload-Induced Osteocyte Apoptosis Stimulates Osteoclast Differentiation Through Increasing Osteocytic RANKL Production In Vitro.
    Yang J; Dong D; Luo X; Zhou J; Shang P; Zhang H
    Calcif Tissue Int; 2020 Nov; 107(5):499-509. PubMed ID: 32995951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of low-magnitude, high-frequency vibration on osteocytes in the regulation of osteoclasts.
    Lau E; Al-Dujaili S; Guenther A; Liu D; Wang L; You L
    Bone; 2010 Jun; 46(6):1508-15. PubMed ID: 20211285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Connexin 43 deficiency desensitizes bone to the effects of mechanical unloading through modulation of both arms of bone remodeling.
    Lloyd SA; Loiselle AE; Zhang Y; Donahue HJ
    Bone; 2013 Nov; 57(1):76-83. PubMed ID: 23891909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of RANKL delivery to the osteoclast precursor cell surface.
    Honma M; Ikebuchi Y; Suzuki H
    J Bone Miner Metab; 2021 Jan; 39(1):27-33. PubMed ID: 33047191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production.
    Delgado-Calle J; Hancock B; Likine EF; Sato AY; McAndrews K; Sanudo C; Bruzzaniti A; Riancho JA; Tonra JR; Bellido T
    FASEB J; 2018 May; 32(5):2878-2890. PubMed ID: 29401593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Regulation of bone homeostasis by bone cells].
    Nakashima T
    Clin Calcium; 2013 Feb; 23(2):218-28. PubMed ID: 23354089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upregulation of osteopontin by osteocytes deprived of mechanical loading or oxygen.
    Gross TS; King KA; Rabaia NA; Pathare P; Srinivasan S
    J Bone Miner Res; 2005 Feb; 20(2):250-6. PubMed ID: 15647819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors.
    Toscani D; Palumbo C; Dalla Palma B; Ferretti M; Bolzoni M; Marchica V; Sena P; Martella E; Mancini C; Ferri V; Costa F; Accardi F; Craviotto L; Aversa F; Giuliani N
    J Bone Miner Res; 2016 Apr; 31(4):815-27. PubMed ID: 26551485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.